Aldose reductase mediates retinal microglia activation.

Area of Science:

• Ophthalmology
• Immunology
• Cell Biology

Background:

• Retinal microglia (RMG) are key immune cells in the eye, monitoring for inflammation.
• Under stress, RMG activate, migrate to different retinal layers, and secrete pro-inflammatory cytokines.
• Aldose reductase (AR) inhibitors show potential in downregulating RMG pro-inflammatory activity.

Purpose of the Study:

• To investigate the role of aldose reductase (AR) in retinal microglia (RMG) activation and migration in vivo.
• To evaluate the therapeutic potential of AR inhibition in inflammatory eye conditions.

Main Methods:

• Utilized CX3CR1(GFP) mice with AR mutant alleles to study AR's function in RMG.
• Administered LPS to induce inflammation and observed RMG activation and migration.
• Assessed ocular levels of pro-inflammatory cytokines like TNF-α and CX3CL-1.

Main Results:

• LPS induced RMG activation and migration in wild-type mice.
• AR inhibitors, AR null mice, or reduced AR expression largely prevented LPS-induced RMG activation and migration.
• AR overexpression exacerbated RMG activation and migration.
• AR inhibition or deficiency significantly reduced ocular TNF-α and CX3CL-1 levels.

Conclusions:

• Aldose reductase (AR) plays a significant role in activating and migrating retinal microglia (RMG).
• AR expression in RMG may contribute to the inflammatory processes in eye diseases such as uveitis and diabetic retinopathy.
• Targeting AR could be a potential therapeutic strategy for managing ocular inflammation.